3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(CAS: 86499-35-6)

The compound 3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (CAS: 86499-35-6) falls under regulatory guidelines such as GHS (Global Harmonized System of Classification and Labeling of Chemicals) for classification and labeling. It may also be subject to REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the EU, which requires pre-market notification and assessment of the substance's potential environmental and health impacts. FDA and EPA guidelines may also apply for specific uses and safety in the US, including handling and disposal of waste containing the compound.

While 3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (CAS: 86499-35-6) is a specific compound, there are alternative reagents and analogs that can be used in synthesis, such as other benzazepinone derivatives or related amino compounds. These alternatives may offer similar functional groups or properties, providing flexibility in chemical synthesis.

The market for 3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (CAS: 86499-35-6) is driven by its use in pharmaceuticals and research. Emerging trends include its application in the development of new drugs and as a building block in structural biology. Research is also focusing on its biosynthesis and potential in medicinal chemistry. Market trends suggest increasing demand as it continues to be explored for its therapeutic potential and synthetic utility.

Waste containing 3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (CAS: 86499-35-6) should be collected in appropriate containers and disposed of according to local and international regulations. Incineration or professional waste disposal services are recommended to ensure environmental safety. Precautions include proper handling to prevent spills and contamination, and the use of personal protective equipment. Compliance with regulations such as the Resource Conservation and Recovery Act (RCRA) in the US is essential for waste management.